Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
DEL PRIS
SecurityDE:10V / Immunic, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership407 shares
Latest Disclosed Value $ 419
Jpmorgan Chase & Co ownership in 10V / Immunic, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 407 shares of Immunic, Inc. (DE:10V) valued at $419 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 407 shares of Immunic, Inc.. The current value of the position is $6,769 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 IMMUNIC COMMON 4525EP101 407 0 0.00 0 0.0000
2026-05-13 2026-03-31 13F IMMUNIC COMMON 4525EP101 0 -100.00 0
2026-02-11 2025-12-31 13F IMMUNIC COMMON 4525EP101 407 -20,300 -98.03 0 -100.00 0.0000
2025-11-26 2025-09-30 13F/A-1 IMMUNIC COMMON 4525EP101 20,707 11,998 137.77 18 200.00 0.0000
2025-11-07 2025-09-30 13F IMMUNIC COMMON 4525EP101 20,707 11,998 18 0.0000
2025-08-12 2025-06-30 13F IMMUNIC COMMON 4525EP101 8,709 7,444 588.46 6 500.00 0.0000
2025-05-12 2025-03-31 13F IMMUNIC COMMON 4525EP101 1,265 -4,951 -79.65 1 -83.33 0.0000
2025-02-12 2024-12-31 13F IMMUNIC COMMON 4525EP101 6,216 5,809 1,427.27 6 0.0000
2024-12-26 2024-09-30 13F/A-1 IMMUNIC COMMON 4525EP101 407 0 0.00 1 0.0000
2024-11-08 2024-09-30 13F IMMUNIC COMMON 4525EP101 407 0 1 0.0000
2024-12-26 2024-06-30 13F/A-1 IMMUNIC COMMON 4525EP101 407 0 0.00 0 0.0000
2024-08-12 2024-06-30 13F IMMUNIC COMMON 4525EP101 407 0 0 0.0000
2024-12-26 2024-03-31 13F/A-1 IMMUNIC COMMON 4525EP101 407 0 0.00 1 0.0000
2024-05-10 2024-03-31 13F IMMUNIC COMMON 4525EP101 407 0 1 0.0000
2024-12-26 2023-12-31 13F/A-1 IMMUNIC COMMON 4525EP101 407 0 0.00 1 0.0000
2024-02-12 2023-12-31 13F IMMUNIC COMMON 4525EP101 407 0 1 0.0000
2023-11-14 2023-09-30 13F IMMUNIC COMMON 4525EP101 407 0 0.00 1 -100.00 0.0000
2023-08-11 2023-06-30 13F IMMUNIC COMMON 4525EP101 407 0 0.00 1 0.00 0.0000
2023-05-18 2023-03-31 13F/A-1 IMMUNIC COMMON 4525EP101 407 -24,496 -98.37 1 0.0000
2023-05-11 2023-03-31 13F IMMUNIC COMMON 4525EP101 407 -24,496 1 0.0000
2023-02-13 2022-12-31 13F IMMUNIC COMMON 4525EP101 24,903 22,901 1,143.91 0 -100.00 0.0000
2022-11-14 2022-09-30 13F IMMUNIC COMMON 4525EP101 2,002 -788 -28.24 6 -33.33 0.0000
2022-08-11 2022-06-30 13F IMMUNIC COMMON 4525EP101 2,790 -10,859 -79.56 9 -94.16 0.0000
2022-05-11 2022-03-31 13F IMMUNIC COMMON 4525EP101 13,649 2,387 21.20 154 42.59 0.0000
2022-02-11 2021-12-31 13F/A-1 IMMUNIC COMMON 4525EP101 11,262 965 9.37 108 20.00 0.0000
2022-02-10 2021-12-31 13F IMMUNIC COMMON 4525EP101 11,262 965 108 0.0000
2021-11-12 2021-09-30 13F IMMUNIC COMMON 4525EP101 10,297 1,788 21.01 90 -13.46 0.0000
2021-08-12 2021-06-30 13F IMMUNIC COMMON 4525EP101 8,509 6,409 305.19 104 215.15 0.0000
2021-05-12 2021-03-31 13F IMMUNIC COMMON 4525EP101 2,100 -377 -15.22 33 -13.16 0.0000
2021-02-19 2020-12-31 13F/A-1 IMMUNIC COMMON 4525EP101 2,477 401 19.32 38 -2.56 0.0000
2021-02-11 2020-12-31 13F IMMUNIC COMMON 4525EP101 2,477 401 38 0.9398
2020-11-12 2020-09-30 13F/A-1 IMMUNIC COMMON 4525EP101 2,076 -859 -29.27 39 8.33 0.0000
2020-11-12 2020-09-30 13F IMMUNIC COMMON 4525EP101 2,076 39
2020-08-11 2020-06-30 13F IMMUNIC COMMON 4525EP101 2,935 2,935 36 0.0000
2020-05-12 2020-03-31 13F IMMUNIC COMMON 4525EP101 0 -6 -100.00 0 0.0000
2020-02-11 2019-12-31 13F IMMUNIC COMMON 4525EP101 6 -1,269 -99.53 0 -100.00
2019-11-12 2019-09-30 13F IMMUNIC COMMON 4525EP101 1,275 1,275 13 0.0000
2019-08-07 2019-06-30 13F VITAL THERAPIES COMMON 92847R104 0 -7,360 -100.00 0 -100.00
2019-05-07 2019-03-31 13F VITAL THERAPIES COMMON 92847R104 7,360 -3,434 -31.81 1 -50.00 0.0000
2019-02-11 2018-12-31 13F VITAL THERAPIES COMMON 92847R104 10,794 3,753 53.30 2 0.00 0.0000
2018-11-13 2018-09-30 13F/A-1 VITAL THERAPIES COMMON 92847R104 7,041 867 14.04 2 -95.24 0.0000
2018-11-07 2018-09-30 13F VITAL THERAPIES COMMON 92847R104 7,041 867 2
2018-08-14 2018-06-30 13F VITAL THERAPIES COMMON 92847R104 6,174 6,174 42 0.0000
2018-05-10 2018-03-31 13F VITAL THERAPIES COMMON 92847R104 0 -64,301 -100.00 0 -100.00
2018-02-13 2017-12-31 13F VITAL THERAPIES COMMON 92847R104 64,301 38,839 152.54 383 211.38 0.0001
2017-11-09 2017-09-30 13F VITAL THERAPIES COMMON 92847R104 25,462 24,241 1,985.34 123 2,975.00 0.0000
2017-08-09 2017-06-30 13F VITAL THERAPIES COMMON 92847R104 1,221 -21,760 -94.69 4 -95.65 0.0000
2017-05-10 2017-03-31 13F VITAL THERAPIES COMMON 92847R104 22,981 -9,620 -29.51 92 -35.21 0.0000
2017-02-06 2016-12-31 13F VITAL THERAPIES COMMON 92847R104 32,601 32,601 0.00 142 0.0000
2016-11-04 2016-09-30 13F VITAL THERAPIES COMMON 92847R104 0 -940 -100.00 0 -100.00
2016-08-08 2016-06-30 13F VITAL THERAPIES COMMON 92847R104 940 -599 -38.92 6 -57.14 0.0000
2016-05-10 2016-03-31 13F VITAL THERAPIES COMMON 92847R104 1,539 662 75.48 14 40.00 0.0000
2016-02-12 2015-12-31 13F VITAL THERAPIES COMMON 92847R104 877 877 10 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.